Keyphrases
Neuropathic Pain
100%
Meta-analysis
100%
Certainty of Evidence
100%
Number Needed to Harm
100%
Non-invasive Neuromodulation
100%
Neuromodulation
30%
Botulinum Neurotoxin (BoNT)
30%
Adverse Events
20%
Opioids
20%
Risk Difference
20%
Special Interest Groups
20%
Capsaicin
20%
Tricyclic Antidepressants
20%
Efficacy Outcomes
20%
Safety Outcomes
20%
Selective Serotonin Reuptake Inhibitors
20%
Lidocaine
20%
Capsaicin 8% Patch
20%
Serotonin-norepinephrine Reuptake Inhibitors
20%
Repetitive Transcranial Magnetic Stimulation (rTMS)
20%
Plaster
20%
Randomized Placebo-controlled Trial
10%
Treatment Outcome
10%
Random-effects Meta-analysis
10%
Pain Intensity
10%
Risk of Bias
10%
Embase
10%
Placebo-controlled
10%
Clinically Significant
10%
Fibromyalgia
10%
Number of Participants
10%
International Association for the Study of Pain
10%
Adult Participants
10%
PubMed
10%
Low Back Pain
10%
Pain Relief
10%
Lived Experience
10%
Effective Treatment
10%
Primary Safety
10%
Clinical Trial Registry
10%
Unmet Needs
10%
Pharmacological Intervention
10%
Cochrane
10%
Prospero
10%
Treatment Recommendations
10%
New Evidence
10%
Recommendations for Practice
10%
Group of Twenty
10%
Risk of Bias Tool
10%
Safe Treatment
10%
Orofacial Pain
10%
Radicular Pain
10%
Sham-controlled Trial
10%
ERA-NET
10%
Third-line Treatment
10%
Group Recommendation
10%
Neuromodulation Techniques
10%
Treatment Uncertainty
10%
International Clinical Trials
10%
Ligand number
10%
Enriched Enrollment Randomized Withdrawal
10%
Withdrawal Design
10%
Patch number
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathic Pain
100%
Number Needed to Harm
100%
Capsaicin
40%
Tricyclic Antidepressant
20%
Serotonin-Norepinephrine Reuptake Inhibitor
20%
Placebo
20%
Lidocaine
20%
Randomized Controlled Trial
10%
Group Trial
10%
Low Back Pain
10%
Complex Regional Pain Syndrome
10%
Fibromyalgia
10%
Radicular Pain
10%
Clostridium Botulinum Type A
10%